EFFICACY AND SAFETY OF PREDNISONE-CYCLOPHOSPHAMIDE COMBINATION AS 1ST LINE THERAPY IN 7 PATIENTS WITH ACQUIRED FACTOR-VIII INHIBITORS

被引：0
|
作者：
BERRUT, G
SHOAAY, I
DUPUIS, JM
MAIGRE, M
FRESSINAUD, P
FRESSINAUD, E
机构：
[1] CHU ANGERS,F-49036 ANGERS,FRANCE
[2] CTR HOSP SAUMUR,SAUMUR,FRANCE
[3] CTR TRANSFUS,ANGERS,FRANCE
来源：
THROMBOSIS AND HAEMOSTASIS | 1993年 / 69卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1105 / 1105
页数：1
相关论文
共 50 条
  • [1] RESPONSES OF AUTOIMMUNE FACTOR-VIII INHIBITORS TO A COMBINATION OF CYCLOPHOSPHAMIDE AND PREDNISONE
    BERRUT, G
    SHOAAY, I
    DUPUIS, JM
    MAIGRE, M
    FRESSINAUD, P
    FRESSINAUD, E
    BLOOD COAGULATION & FIBRINOLYSIS, 1994, 5 (01) : 145 - 146
  • [2] DESMOPRESSIN THERAPY IN PATIENTS WITH ACQUIRED FACTOR-VIII INHIBITORS
    NAOROSEABIDI, SM
    BOND, LR
    CHITOLIE, A
    BEVAN, DH
    LANCET, 1988, 1 (8581): : 366 - 366
  • [3] Treatment of two patients with acquired factor VIII inhibitors using cyclophosphamide and prednisone
    Hertzberg, MS
    Favaloro, E
    Koutts, J
    AMERICAN JOURNAL OF HEMATOLOGY, 2002, 70 (04) : 330 - 331
  • [4] SIGNIFICANCE OF COMBINED CYCLOPHOSPHAMIDE AND PREDNISONE AS 1ST-LINE TREATMENT OF NON-HEMOPHILIC PATIENTS WITH FACTOR-VIII INHIBITOR
    BERRUT, G
    SHOAAY, I
    DUPUIS, JM
    MAIGRE, M
    FRESSINAUD, P
    FRESSINAUD, E
    REVUE DE MEDECINE INTERNE, 1993, 14 (06): : 503 - 503
  • [5] Successful treatment of patients with rheumatic disorders and acquired factor VIII inhibitors with cyclophosphamide and prednisolone combination therapy: Two case reports
    Nishino, Y
    Ueki, K
    Suto, M
    Uchiumi, H
    Ota, F
    Tamura, S
    Kaneko, Y
    Kuroiwa, T
    Tsukada, Y
    Maezawa, A
    Nojima, Y
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2001, 29 (05) : 432 - 436
  • [6] RECOMBINANT FACTOR-VIII FOR THE TREATMENT OF PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A - SAFETY, EFFICACY, AND DEVELOPMENT OF INHIBITORS
    LUSHER, JM
    ARKIN, S
    ABILDGAARD, CF
    SCHWARTZ, RS
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (07): : 453 - 459
  • [7] DETECTION OF FACTOR-VIII AND FACTOR-IX INHIBITORS AFTER 1ST EXPOSURE TO HEAT-TREATED CONCENTRATES
    HASEGAWA, DK
    EDSON, JR
    LANCET, 1987, 1 (8530): : 449 - 449
  • [8] ACQUIRED HEMOPHILIA - A NATURAL-HISTORY STUDY OF 16 PATIENTS WITH FACTOR-VIII INHIBITORS RECEIVING LITTLE OR NO THERAPY
    LOTTENBERG, R
    KENTRO, TB
    KITCHENS, CS
    ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (06) : 1077 - 1081
  • [9] Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors
    Abshire, T
    Kenet, G
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (06) : 899 - 909
  • [10] The Safety and Efficacy of Durvalumab as 1st Line Therapy in Patients with Advanced NSCLC and ECOG PS of 2
    Shaverdashvili, K.
    Reyes, V.
    Wang, H.
    Mehta, D.
    Marsh, C.
    Waas, J. K.
    VanderWeele, R. A.
    Peracha, S. M.
    Liang, H.
    Gerber, D. E.
    Dowell, J.
    Villaruz, L. C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S322 - S322
12345